Persistent Cytokine Expression in Trigeminal Ganglion Latently Infected with Herpes Simplex Virus Type 1

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3542-3549

  Halford, William P ^a   Gebhardt, Bryan M ^a   Carr, Daniel J J ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MESSENGER RNA; PRIMER DNA; RANTES; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY;

ANIMAL; ARTICLE; BLOOD; CELL LINE; CERCOPITHECUS; FEMALE; GENE EXPRESSION; GENETICS; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PATHOGENICITY; TIME; TRIGEMINUS GANGLION; VERO CELL; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOKINES; DNA PRIMERS; FEMALE; GENE EXPRESSION; HERPESVIRUS 1, HUMAN; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; KERATITIS, HERPETIC; MICE; MICE, INBRED ICR; RANTES; RNA, MESSENGER; TIME FACTORS; TRIGEMINAL GANGLION; TUMOR NECROSIS FACTOR-ALPHA; VERO CELLS;

EID: 0030587885     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Topp, K. S., L. B. Meade, and J. H. LeVail. 1994. Microtubule polarity in the peripheral processes of trigeminal ganglion cells: relevance for the retrograde transport of herpes simplex virus. J. Neurosci. 14:318.
2. Liu, T., Q. Tang, and R. L. Hendricks. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:264.
3. Rock, D. L., and N. W. Fraser. 1985. Latent herpes simplex virus type 1 DNA contains two copies of the virion DNA joint region. J. Virol. 55:849.
4. Deshmane, S. L., and N. W. Fraser. 1989. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J. Virol. 63:943.
5. Fraser, N. W. 1992. The latency-associated transcripts of herpes simplex virus: RNA in search of a function. Virology 191:1.
6. Farrell, M. J., J. M. Hill, T. P. Margolis, J. G. Stevens, E. K. Wagner, and L. T. Feldman. 1993. The herpes simplex virus type 1 reactivation function lies outside the latency-associated transcript open reading frame ORF-2. J. Virol. 67:3653.
7. Abghari, S. Z., R. D. Stulting, S. M. Nigida, Jr., D. N. Downer, and A. J. Nahmias. 1986. Comparative replication of HSV-1 in BALB/c and C57BL/6 mouse embryo fibroblasts in vitro. Invest. Ophthalmol. Vis. Sci. 27:909.
8. Simmons, A., D. C. Tscharke, and P. Speck. 1992. The role of immune mechanisms in control of herpes simplex virus infection of the peripheral nervous system. Curr. Top. Microbiol. Immunol. 179:31.
9. Zawatsky, R., I. Gresser, E. DeMayer, and H. Kirchner. 1982. The role of interferon in the resistance of C57BL/6 mice to various doses of herpes simplex virus type 1. J. Infect. Dis. 146:405.
10. Mehta, A., J. Maggioncalda, O. Bagasra, S. Thikkavarapu, P. Saikumari, T. Valyi-Nagy, N. W. Fraser, and T. M. Block. 1995. In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology 206:633.
11. Hill, J. M., B. M. Gebhardt, R. Wen, A. M. Bouterie, H. W. Thompson, R. J. O'Callaghan, W. P. Halford, and H. E. Kaufman. Quantitation of HSV-1 DNA and LAT in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency. J. Virol. 70:3137.
12. Simmons, A., and D. C. Tscharke. 1992. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175:1337.
13. Manickan, E., and B. T. Rouse, 1995. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse models. J. Virol. 69:8178.
14. 2+ cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68:825.
15. Bonneau, R. H., and Jennings, S. R. 1989. Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. J. Virol. 63:1480.
16. Igietseme, J. U., J. W. Streilein, F. Miranda, S. J. Feinerman, and S. S. Atherton. 1991. Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes. J. Virol. 65:763.
17. Fraser, N. W., and T. Valyi-Nagy. 1993. Viral, neuronal, and immune factors which may influence herpes simplex virus latency and reactivation. Microb. Pathog. 15:83.
18. Linnavuori, K., and T. Hovi. 1983. Restricted replication of herpes simplex virus in human monocyte cultures: role of interferon. Virology 130:1.
19. Feduchi, E., M. A. Alonso, and L. Carrasco. 1989. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63:1354.
20. Cantin, E. M., D. R. Hinton, J. Chen, and H. Openshaw. 1995. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:4898.
21. Shimeld, C., J. L. Whiteland, S. M. Nicholls, E. Grinfeld, D. L. Easty, H. Gao, and T. J. Hill. 1995. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61:7.
22. S ekizawa, T., H. Openshaw, C. Wohlenberg, and A. L. Notkins. 1980. Latency of herpes simplex virus in absence of neutralizing antibody: model for reactivation. Science 210:1026.
23. National Institutes of Health Guidelines on the Care and Use of Laboratory Animals. National Research Council, Department of Health, Education, and Welfare, Washington, DC, Publication 85-23, revised 1985.
24. Farrell, M. J., A. T. Dobson, and L. T. Feldman. 1991. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. USA 88:790.
25. Oakes, J. E. 1975. Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection. Infect. Immun. 12:166.
26. DeStasio, P. R., and M. W. Taylor. 1990. Specific effect of interferon on the herpes simplex virus type 1 transactivation event. J. Virol. 64:2588.
27. Rossol-Voth, R., S. Rossol, K. H. Schütt, S. Corridori, W. de Cian, and D. Falke. 1991. In vivo protective effect of tumor necrosis factor α against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 72:143.
28. Karupiah, G., Q. Xie, R. M. L. Buller, C. Nathan, C. Duarte, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261:1445.
29. Giles, P. N., G. Fey, and F. V. Chisari. 1992. Tumor necrosis factor-alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66:3955.
30. Guilhot, S., L. G. Guidotti, and F. V. Chisari. 1993. Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a post-transcriptional mechanism. J. Virol. 67:7444.
31. Guidotti, L. G., K. Ando, M. V. Hobbs, T. Ishikawa, R. D. Runkel, R. D. Schreiber, and F. V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91:3764.
32. Gebhardt, B. M., and J. M. Hill. 1988. T lymphocytes in the trigeminal ganglia of rabbits during corneal HSV infection. Invest. Ophthalmol. Vis. Sci. 29:1683.
33. Openshaw, H., L. V. Shavrina-Asher, C. Wohlenberg, T. Sekizawa, and A. L. Notkins. 1979. Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation. J. Gen. Virol. 44:205.
34. Halford, W. P., B. M. Gebhardt, and D. J. J. Carr. 1996. Mechanisms of herpes simplex virus type 1 reactivation. J. Virol. 70:5051.
35. Tullo, A. B., C. Shimeld, W. A. Blyth, T. J. Hill, and D. I. Easty. 1982. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse. J. Gen. Virol. 63:95.
36. Willey, D. E., M. D. Trousdale, and A. B. Nesburn. 1984. Reactivation of murine latent HSV infection by epinephrine iontophoresis. Invest. Ophthalmol. Vis. Sci. 25:945.
37. Green, M. T., R. J. Courtney, and E. C. Dunkel. 1981. Detection of an immediate early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals. Infect. Immun. 34:987.
38. Kramer, M., and D. M. Coen. 1995. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69:1389.
39. Doerig, C., L. I. Pizer, and C. L. Wilcox. 1991. An antigen encoded by the latency-associated transcript in neuronal cell cultures latently infected with herpes simplex virus type 1. J. Virol 65:2724.
40. Ramakrishnan, R., M. Levine, and D. J. Fink. 1994. PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J. Virol. 68:7083.
41. Joly, E., L. Mucke, and M. B. A. Oldstone. 1991. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253: 1283.
42. Bishop, S. A., and T. J. Hill. 1989. Herpes simplex virus infection in the central nervous system: immune response to myelin basic protein. J. Neurol. Sci. 91:109.
43. Banks, T. A., and B. T. Rouse. 1992. Herpesviruses: immune escape artists? Clin. Infect. Dis. 14:933.